Table 2.
Demographic and laboratory test data results of enrolled patients
| Characteristic | Overall (n = 363) |
Patency group (n = 242) |
Restenosis group (n = 121) |
P value |
|---|---|---|---|---|
| Sex (%) | 1.000 | |||
| Male | 219 (60.3) | 146 (60.3) | 73 (60.3) | |
| Female | 144 (39.7) | 96 (39.7) | 48 (39.7) | |
| Age (year) | 62.6 ± 10.5 | 62.3 ± 10.6 | 63.3 ± 10.2 | 0.373 |
| BMI (Kg/m2) | 23.6 ± 4.2 | 23.3 ± 3.8 | 24.2 ± 4.9 | 0.028 |
| Smoking (%) | 1.000 | |||
| No | 210 (57.9) | 140 (57.9) | 70 (57.9) | |
| Yes | 153 (42.1) | 102 (42.1) | 51 (42.1) | |
| Alcohol (%) | 1.000 | |||
| No | 219 (60.3) | 146 (60.3) | 73 (60.3) | |
| Yes | 144 (39.7) | 96 (39.7) | 48 (39.7) | |
| Leukocyte (109/L) | 6.4 (5.4, 7.7) | 6.3 (5.4, 7.7) | 6.4 (5.6, 7.7) | 0.509 |
| Erythrocyte (109/L) | 4.3 (4.0, 4.6) | 4.3 (4.0, 4.6) | 4.3 (4.0, 4.7) | 0.310 |
| Platelet (109/L) | 212.5 (173.0, 258.2) | 213.0 (171.8, 259.0) | 212.0 (174.5, 245.8) | 0.743 |
| ALT (U/L) | 18.0 (12.0, 41.0) | 21.0 (12.0, 41.0) | 17.0 (12.0, 30.0) | 0.032 |
| AST (U/L) | 20.0 (16.0, 31.0) | 20.0 (16.0, 31.0) | 19.0 (13.5, 31.0) | 0.037 |
| ALB (g/L) | 42.1 (39.5, 44.2) | 42.0 (39.0, 44.2) | 42.1 (40.0, 44.2) | 0.703 |
| Total bilirubin (µmol/L) | 8.8 ± 4.1 | 8.9 ± 3.6 | 8.6 ± 4.9 | 0.487 |
| Direct bilirubin (µmol/L) | 4.1 ± 2.1 | 4.2 ± 1.9 | 4.0 ± 2.4 | 0.336 |
| TC (mmol/L) | 3.6 (2.9, 4.4) | 3.6 (2.9, 4.4) | 3.6 (2.8, 4.3) | 0.397 |
| TG (mmol/L) | 1.5 (1.0, 2.1) | 1.5 (1.0, 2.1) | 1.5 (1.0, 2.0) | 0.654 |
| Glucose(mmol/L) | 7.1 (5.7, 9.1) | 7.0 (5.7, 8.8) | 7.6 (6.0, 10.2) | 0.013 |
| UA (mmol/L) | 285.0 (237.0, 346.0) | 279.0 (227.8, 343.0) | 292.0 (253.0, 351.0) | 0.062 |
| HDL-C (mmol/L) | 1.0 (0.8, 1.2) | 1.0 (0.8, 1.2) | 1.0 (0.8, 1.1) | 0.210 |
| LDL-C (mmol/L) | 2.6 (1.7, 3.0) | 2.3 (1.6, 3.0) | 2.9 (1.9, 3.1) | 0.003 |
| eGFR (ml/min/1.73m2) | 96.0 (85.9, 103.7) | 97.1 (86.2, 104.4) | 95.0 (84.4, 103.0) | 0.151 |
| TyG | 9.1 (8.7, 9.5) | 9.0 (8.6, 9.5) | 9.1 (8.7, 9.5) | 0.143 |
| METS-IR | 47.2 (41.7, 55.1) | 46.8 (41.5, 53.7) | 49.3 (42.2, 59.3) | 0.008 |
| TG/HDL | 1.6 (1.0, 2.5) | 1.4 (0.9, 2.4) | 1.8 (1.3, 2.7) | < 0.001 |
| TyG-BMI | 210.9 (193.1, 246.5) | 204.4 (185.5, 232.4) | 215.5 (202.0, 268.6) | 0.004 |
| Hypertension (%) | 0.546 | |||
| No | 149 (41.0) | 102 (42.1) | 47 (38.8) | |
| Yes | 214 (59.0) | 140 (57.9) | 74 (61.2) | |
| Diabetes (%) | 0.001 | |||
| No | 170 (46.8) | 128 (52.9) | 42 (34.7) | |
| Yes | 193 (53.2) | 114 (47.1) | 79 (65.3) | |
| Coronary heart disease (%) | < 0.001 | |||
| No | 287 (79.1) | 208 (86) | 79 (65.3) | |
| Yes | 76 (20.9) | 34 (14) | 42 (34.7) | |
| Stroke (%) | < 0.001 | |||
| No | 256 (70.5) | 187 (77.3) | 69 (57) | |
| Yes | 107 (29.5) | 55 (22.7) | 52 (43) | |
| Antihypertensive medications (%) | 0.546 | |||
| No | 149 (41.0) | 102 (42.1) | 47 (38.8) | |
| Yes | 214 (59.0) | 140 (57.9) | 74 (61.2) | |
| Diabetes medication (%) | 0.603 | |||
| No | 181 (49.9) | 123 (50.8) | 58 (47.9) | |
| Yes | 182 (50.1) | 119 (49.2) | 63 (52.1) | |
| TASCII classification | 0.444 | |||
| A | 90 (24.8) | 58 (24) | 32 (26.4) | |
| B | 141 (38.8) | 93 (38.4) | 48 (39.7) | |
| C | 102 (28.1) | 67 (27.7) | 35 (28.9) | |
| D | 30 (8.3) | 24 (9.9) | 6 (5) |
ALT: alanine aminotransferase, AST: aspartate aminotransferase, ALB: albumin, TC: total cholesterol, TG: triglycerides, UA: uric acid, eGFR: estimated glomerular filtration rate, TASC II: the TransAtlantic Inter-Society Consensus II